Evidence map›Paper›PMID 30187880›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2018

[Quercetin attenuates Ox-LDL-induced calcification in vascular smooth muscle cells by regulating ROS-TLR4 signaling pathway].

Qingchun Liang, Yanting Chen, Chuanxiang Li, Lihe Lu

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. NovelFrontiers in pharmacology · 2024
    Article
  4. Research progress of quercetin in cardiovascular disease.Frontiers in cardiovascular medicine · 2023
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. [Quercetin alleviates lipopolysaccharide-induced acute kidney injury in mice by suppressing TLR4/NF-κB pathway].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Qingchun LiangDepartment of Anesthesiology, Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.
Yanting ChenDepartment of Pathophysiology, Zhongshan Medical School, Sun Yat-Sen University, Guangzhou 510080, China.
Chuanxiang LiDepartment of Anesthesiology, Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.
Lihe LuDepartment of Pathophysiology, Zhongshan Medical School, Sun Yat-Sen University, Guangzhou 510080, China.
Sun Yat-sen University · CNThird Affiliated Hospital of Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine whether quercetin inhibits oxidized low-density lipoprotein (Ox-LDL)-induced osteogenic differentiation and calcification of vascular smooth muscle cells (VSMCs) and understand the underlying mechanism.

methodsThe calcification of human VSMCs following Ox-LDL treatment was assessed using alizarin red staining and by detecting ALP activity. The mRNA expressions of the bone-related genes including Msx2, BMP2 and Osterix, and the contractile proteins including SMA and SM22a were analyzed using qPCR. The effects of quercetin were investigated on OxLDL-induced VSMC calcification and changes in ALP activity, expressions of Msx2, BMP2, Osterix, SMA and SM22a, ROS levels and SOD activity. The effect of Toll like receptor 4 (TLR4) silencing mediated by siRNA transfection on cell calcification, ALP activity, gene expressions and ROS levels were investigated.

resultsOx-LDL treatment promoted VSMC calcification and up-regulated TLR4 expression. Quercetin treatment significantly attenuated Ox-LDL-induced VSMC calcification, reduced ALP activity, down-regulated the expression levels of Msx2, BMP2 and Osterix, and up-regulated the expressions of vascular smooth muscle contractile proteins SMA and SM22a. In addition, Quercetin treatment markedly increased SOD activity, reduced ROS levels and TLR4 expression in VSMCs. Silencing TLR4 expression using TLR4 siRNA also significantly decreased calcification of the VSMCs.

conclusionsQuercetin inhibits Ox-LDL-induced VSMC calcification in VSMCs possibly by targeting the ROS/TLR4 signaling pathway.

Indexed as

ActinsBone Morphogenetic Protein 2Cell DifferentiationCells, CulturedHomeodomain ProteinsHumansLipoproteins, LDLMuscle, Smooth, VascularMyocytes, Smooth MuscleOsteogenesisQuercetinReactive Oxygen SpeciesRNA, MessengerRNA, Small InterferingSp7 Transcription FactorToll-Like Receptor 4ActinsBMP2 protein, humanBone Morphogenetic Protein 2Homeodomain ProteinsLipoproteins, LDLMSX2 proteinoxidized low density lipoproteinQuercetinReactive Oxygen SpeciesRNA, MessengerRNA, Small InterferingSP7 protein, humanSp7 Transcription FactorTLR4 protein, humanToll-Like Receptor 4osteogenic differentiationoxidized low-density lipoproteinquercetinvascular calcificationvascular smooth muscle cells

Identifiers

PMID30187880
PMCPMC6744032
OpenAlexW2890366512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.